{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:09:52Z","timestamp":1779347392552,"version":"3.51.4"},"reference-count":42,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/zihr3267","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T07:24:09Z","timestamp":1764228249000},"page":"8843-8857","source":"Crossref","is-referenced-by-count":0,"title":["Clinical efficacy and psychological benefits of combination therapy in elderly patients with hypertension"],"prefix":"10.62347","volume":"17","author":[{"given":"Putian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","unstructured":"Fuchs FD and Whelton PK. High blood pressure and cardiovascular disease. Hypertension 2020; 75: 285-292.","journal-title":"Hypertension"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Korosi B, Laszlo A, Tabak A, Batta D, Lenart L, Fekete A, Eorsi D, Cseprekal O, Tisler A, Nemcsik-Bencze Z, Gonda X, Rihmer Z and Nemcsik J. The impact of currently recommended antihypertensive therapy on depression and other psychometric parameters: preliminary communication. Neuropsychopharmacol Hung 2017; 19: 11-22.","DOI":"10.1016\/S0924-977X(17)31527-4"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/HJH.0000000000000850","article-title":"Comorbidity of depression and anxiety disorders in patients with hypertension","volume":"34","author":"Graham","year":"2016","unstructured":"Graham N and Smith DJ. Comorbidity of depression and anxiety disorders in patients with hypertension. J Hypertens 2016; 34: 397-8.","journal-title":"J Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Figueiredo CA, Nunes DP, Fusco SB and Saidel MGB. Mental health of elderly hypertensive patients in primary health care: an integrative review. Aquichan 2023; 23: e2347.","DOI":"10.5294\/aqui.2023.23.4.7"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Yao YJ, Gui M and Cai SK. A network meta-analysis comparative the efficacy of angiotensin-converting enzyme inhibitors and calcium channel blockers in hypertension. Medicine (Baltimore) 2024; 103: e37856.","DOI":"10.1097\/MD.0000000000037856"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14796678.2025.2465218","article-title":"The role of single-pill ACE inhibitor\/ccb combination for hypertension: an Algerian view via the nominal group technique","volume":"21","author":"Kichou","year":"2025","unstructured":"Kichou B, Bouraghda A, Lahmar HMA, Amara S, Aoudia Y, Benchabi Y, Haddoum F, Kachenoura A, Laredj N, Manamani L, Bouafia MTC and Chettibi M. The role of single-pill ACE inhibitor\/ccb combination for hypertension: an Algerian view via the nominal group technique. Future Cardiol 2025; 21: 155-166.","journal-title":"Future Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1097\/HJH.0000000000003741","article-title":"Efficacy and safety of a single-pill versus free combination of perindopril\/indapamide\/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension","volume":"42","author":"Wang","year":"2024","unstructured":"Wang JG, Topouchian J, Bricout-Hennel S, Mu J, Chen L, Li P, He S, Luo S, Jiang W, Jiang Y, Sun Y, Zhang Y and Asmar R. Efficacy and safety of a single-pill versus free combination of perindopril\/indapamide\/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension. J Hypertens 2024; 42: 1373-1381.","journal-title":"J Hypertens"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V and Desormais I; ESC Scientific Document Group. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104.","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.3390\/ijerph17238961","article-title":"Exploring perceived stress among students in turkey during the COVID-19 pandemic","volume":"17","author":"Aslan","year":"2020","unstructured":"Aslan I, Ochnik D and &#xC7;&#x131;nar O. Exploring perceived stress among students in turkey during the COVID-19 pandemic. Int J Environ Res Public Health 2020; 17: 8961.","journal-title":"Int J Environ Res Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL and Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16: 606-13.","journal-title":"J Gen Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1111\/jch.13949","article-title":"Poor sleep quality is associated with cardiac autonomic dysfunction in treated hypertensive men","volume":"22","author":"Oliveira-Silva L","year":"2020","unstructured":"Oliveira-Silva L, Pe&#xE7;anha T, Fecchio RY, Rezende RA, Abreu A, Silva G, Mion-Junior D, Cipolla-Neto J, Forjaz CLM and Brito LC. Poor sleep quality is associated with cardiac autonomic dysfunction in treated hypertensive men. J Clin Hypertens (Greenwich) 2020; 22: 1484-1490.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/ejvs.2002.1946","article-title":"Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis","volume":"26","author":"AR","year":"2003","unstructured":"Naylor AR, Rothwell PM and Bell PR. Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg 2003; 26: 115-29.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurad.2018.05.003","article-title":"Risk prediction of cerebrovascular events with carotid plaque magneitc resonance analysis: a meta-analysis","volume":"46","author":"Jiang","year":"2019","unstructured":"Jiang B, He D, Zhang L and Ye M. Risk prediction of cerebrovascular events with carotid plaque magneitc resonance analysis: a meta-analysis. J Neuroradiol 2019; 46: 117-123.","journal-title":"J Neuroradiol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1161\/01.STR.30.9.1751","article-title":"The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients","volume":"30","author":"Ferguson","year":"1999","unstructured":"Ferguson GG, Eliasziw M, Barr HW, Clagett GP, Barnes RW, Wallace MC, Taylor DW, Haynes RB, Finan JW, Hachinski VC and Barnett HJ. The North American Symptomatic Carotid Endarterectomy Trial: surgical results in 1415 patients. Stroke 1999; 30: 1751-8.","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","article-title":"0","volume":"67","author":"Chen","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC and Lacouture ME. Grading dermatologic adverse events of cancer treatments: the Common Terminology Criteria for Adverse Events Version 4.0. J Am Acad Dermatol 2012; 67: 1025-39.","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","article-title":"Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension","volume":"18","author":"Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA and Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol 2021; 18: 785-802.","journal-title":"Nat Rev Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40292-020-00420-y","article-title":"Blood pressure target achievement under monotheraphy: a real-life appraisal","volume":"27","author":"Tocci","year":"2020","unstructured":"Tocci G, Presta V, Citoni B, Figliuzzi I, Bianchi F, Ferrucci A and Volpe M. Blood pressure target achievement under monotheraphy: a real-life appraisal. High Blood Press Cardiovasc Prev 2020; 27: 587-596.","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.amjmed.2011.12.010","article-title":"Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients","volume":"125","author":"Ogawa","year":"2012","unstructured":"Ogawa H, Kim-Mitsuyama S, Matsui K, Jinnouchi T, Jinnouchi H and Arakawa K; OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study Group. Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients. Am J Med 2012; 125: 981-90.","journal-title":"Am J Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1007\/s12325-014-0132-x","article-title":"Efficacy and safety of valsartan\/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study","volume":"31","author":"Hu","year":"2014","unstructured":"Hu D, Liu L and Li W. Efficacy and safety of valsartan\/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study. Adv Ther 2014; 31: 762-75.","journal-title":"Adv Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/j.clinthera.2017.08.013","article-title":"Comparison of fixed-dose combinations of Amlodipine\/Losartan Potassium\/Chlorthalidone and Amlodipine\/Losartan Potassium in patients with stage 2 hypertension inadequately controlled with Amlodipine\/Losartan Potassium: a randomized, double-blind, multicenter, phase III study","volume":"39","author":"Hong","year":"2017","unstructured":"Hong SJ, Jeong HS, Han SH, Chang KY, Hong BK, Lee BK, Chae SC, Kim WS, Park CG, Heo JH, Lee SU, Kim YD, Kim KS, Choi JH, Kang HJ, Kim JJ, Kang SM, Choi YJ, Shin JH, Chun KJ, Shin DG, Park SH, Kwan J, Choi YJ, Jeong MH, Chae JK, Kim DW, Cho JR, Han KR, Won KH, Park SH, Lee SK, Kim SH, Jung J and Kim CH. Comparison of fixed-dose combinations of Amlodipine\/Losartan Potassium\/Chlorthalidone and Amlodipine\/Losartan Potassium in patients with stage 2 hypertension inadequately controlled with Amlodipine\/Losartan Potassium: a randomized, double-blind, multicenter, phase III study. Clin Ther 2017; 39: 2049-2060.","journal-title":"Clin Ther"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/pds.4884","article-title":"Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: a propensity score-matched cohort study in the UK Clinical Practice Research Datalink","volume":"28","author":"Marinier","year":"2019","unstructured":"Marinier K, Macouillard P, de Champvallins M, Deltour N, Poulter N and Mancia G. Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: a propensity score-matched cohort study in the UK Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf 2019; 28: 1572-1582.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/HJH.0000000000003074","article-title":"Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis","volume":"40","author":"Brewster","year":"2022","unstructured":"Brewster LM, Boermeester AS, Seedat YK and Van Montfrans GA. Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis. J Hypertens 2022; 40: 629-640.","journal-title":"J Hypertens"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH and Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 2015; 116: 960-75.","journal-title":"Circ Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41440-021-00704-3","article-title":"Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis","volume":"44","author":"Qin","year":"2021","unstructured":"Qin J, He Z, Wu L, Wang W, Lin Q, Lin Y and Zheng L. Prevalence of mild cognitive impairment in patients with hypertension: a systematic review and meta-analysis. Hypertens Res 2021; 44: 1251-1260.","journal-title":"Hypertens Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.biopsych.2020.02.005","article-title":"Angiotensin-converting enzyme inhibitor rapidly ameliorates depressive-type behaviors via bradykinin-dependent activation of mammalian target of rapamycin complex 1","volume":"88","author":"Luo","year":"2020","unstructured":"Luo H, Wu PF, Cao Y, Jin M, Shen TT, Wang J, Huang JG, Han QQ, He JG, Deng SL, Ni L, Hu ZL, Long LH, Wang F and Chen JG. Angiotensin-converting enzyme inhibitor rapidly ameliorates depressive-type behaviors via bradykinin-dependent activation of mammalian target of rapamycin complex 1. Biol Psychiatry 2020; 88: 415-425.","journal-title":"Biol Psychiatry"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/sj.npp.1300921","article-title":"A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding","volume":"31","author":"Saavedra","year":"2006","unstructured":"Saavedra JM, Armando I, Bregonzio C, Juorio A, Macova M, Pavel J and Sanchez-Lemus E. A centrally acting, anxiolytic angiotensin II AT1 receptor antagonist prevents the isolation stress-induced decrease in cortical CRF1 receptor and benzodiazepine binding. Neuropsychopharmacology 2006; 31: 1123-34.","journal-title":"Neuropsychopharmacology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0031-9384(03)00036-2","article-title":"Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats","volume":"78","author":"Srinivasan","year":"2003","unstructured":"Srinivasan J, Suresh B and Ramanathan M. Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats. Physiol Behav 2003; 78: 585-91.","journal-title":"Physiol Behav"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/0004867417721654","article-title":"Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials","volume":"52","author":"DJ","year":"2018","unstructured":"Brownstein DJ, Salagre E, K&#xF6;hler C, Stubbs B, Vian J, Pereira C, Chavarria V, Karmakar C, Turner A, Quevedo J, Carvalho AF, Berk M and Fernandes BS. Blockade of the angiotensin system improves mental health domain of quality of life: a meta-analysis of randomized clinical trials. Aust N Z J Psychiatry 2018; 52: 24-38.","journal-title":"Aust N Z J Psychiatry"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1053136","DOI":"10.3389\/fimmu.2022.1053136","article-title":"Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety","volume":"13","author":"Sizhu","year":"2023","unstructured":"Sizhu G and Fang D. Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety. Front Immunol 2023; 13: 1053136.","journal-title":"Front Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s13311-023-01435-8","article-title":"The renin angiotensin system as a therapeutic target in traumatic brain injury","volume":"20","author":"Villapol","year":"2023","unstructured":"Villapol S, Janatpour ZC, Affram KO and Symes AJ. The renin angiotensin system as a therapeutic target in traumatic brain injury. Neurotherapeutics 2023; 20: 1565-1591.","journal-title":"Neurotherapeutics"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1053136","DOI":"10.3389\/fimmu.2022.1053136","article-title":"Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety","volume":"13","author":"Gong","year":"2023","unstructured":"Gong S and Deng F. Renin-angiotensin system: the underlying mechanisms and promising therapeutical target for depression and anxiety. Front Immunol 2023; 13: 1053136.","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1749-6632.2003.tb07078.x","article-title":"L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning","volume":"985","author":"Shinnick-Gallagher","year":"2003","unstructured":"Shinnick-Gallagher P, McKernan MG, Xie J and Zinebi F. L-type voltage-gated calcium channels are involved in the in vivo and in vitro expression of fear conditioning. Ann N Y Acad Sci 2003; 985: 135-49.","journal-title":"Ann N Y Acad Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jphs.2020.03.003","article-title":"Benzothiazepines, diltiazem and JTV-519, exert an anxiolytic-like effect via neurosteroid biosynthesis in mice","volume":"143","author":"Yoshizawa","year":"2020","unstructured":"Yoshizawa K, Nakashima K, Tabuchi M, Okumura A, Nakatake Y, Yamada M, Tsuneoka Y and Higashi T. Benzothiazepines, diltiazem and JTV-519, exert an anxiolytic-like effect via neurosteroid biosynthesis in mice. J Pharmacol Sci 2020; 143: 234-237.","journal-title":"J Pharmacol Sci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s40801-022-00321-7","article-title":"Associations of cardiovascular agents and metformin with depression symptoms: a cross-sectional analysis from the HUNT study, norway","volume":"9","author":"Bojani&#x107","year":"2022","unstructured":"Bojani&#x107; I, Bjerkeset O, Williams LJ, Berk M, Sund ER and Sletvold H. Associations of cardiovascular agents and metformin with depression symptoms: a cross-sectional analysis from the HUNT study, norway. Drugs Real World Outcomes 2022; 9: 503-516.","journal-title":"Drugs Real World Outcomes"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","article-title":"Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders","volume":"68","author":"Boal","year":"2016","unstructured":"Boal AH, Smith DJ, McCallum L, Muir S, Touyz RM, Dominiczak AF and Padmanabhan S. Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders. Hypertension 2016; 68: 1132-1138.","journal-title":"Hypertension"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","article-title":"From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms","volume":"14","author":"ZD","year":"2017","unstructured":"Kabir ZD, Mart&#xED;nez-Rivera A and Rajadhyaksha AM. From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms. Neurotherapeutics 2017; 14: 588-613.","journal-title":"Neurotherapeutics"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1038\/s41380-022-01615-6","article-title":"Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders","volume":"27","author":"Colbourne","year":"2022","unstructured":"Colbourne L and Harrison PJ. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders. Mol Psychiatry 2022; 27: 3904-3912.","journal-title":"Mol Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/cvr\/cvac110","article-title":"Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects","volume":"119","author":"Carnovale","year":"2023","unstructured":"Carnovale C, Perrotta C, Baldelli S, Cattaneo D, Montrasio C, Barbieri SS, Pompilio G, Vantaggiato C, Clementi E and Pozzi M. Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovasc Res 2023; 119: 647-667.","journal-title":"Cardiovasc Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.clinthera.2024.04.004","article-title":"The efficacy and tolerability of Irbesartan\/Amlodipine combination therapy in patients with essential hypertension whose blood pressure were not controlled by irbesartan monotherapy","volume":"46","author":"Lee","year":"2024","unstructured":"Lee HY, Min KW, Han KA, Kim JS, Ahn JC, Kim MH, Lee JB, Shin SH, Kim CJ, Kim KH, Cho DK, Choi J, Rhee MY, Her SH, Kim W, Na JO, Cho GY, Kim SY, Park GM, Lee BK, Jo SH, Lee BW, Sohn IS, Kim DI, Ihm SH, Lee SH, Chung JW, Cho EJ, Son JW, Oh SJ, Hwang JY, Jeong JO, Han KR, Yoon HJ, Seo SM, Chung WJ, Bae JW, Choi JH, Hyun BJ, Cha JE, Yoo SJ and Shin J. The efficacy and tolerability of Irbesartan\/Amlodipine combination therapy in patients with essential hypertension whose blood pressure were not controlled by irbesartan monotherapy. Clin Ther 2024; 46: 481-489.","journal-title":"Clin Ther"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Karacan G&#xF6;len M, U&#xE7;ar Karabulut K, Kamilo&#x11F;lu M and Yonar A. Pan-immune-inflammation value predicts 3-month functional outcomes in patients with acute ischemic stroke treated with mechanical thrombectomy. Brain Behav 2025; 15: e70397.","DOI":"10.1002\/brb3.70397"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"2976447","DOI":"10.1155\/2021\/2976447","article-title":"Oxidative stress and inflammation are associated with coexistent severe multivessel coronary artery stenosis and right carotid artery severe stenosis in elderly patients","volume":"2021","author":"Li","year":"2021","unstructured":"Li X, Guo D, Hu Y and Chen Y. Oxidative stress and inflammation are associated with coexistent severe multivessel coronary artery stenosis and right carotid artery severe stenosis in elderly patients. Oxid Med Cell Longev 2021; 2021: 2976447.","journal-title":"Oxid Med Cell Longev"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Rosendorff C, Lackland DT, Allison M, Aronow WS, Black HR, Blumenthal RS, Cannon CP, de Lemos JA, Elliott WJ, Findeiss L, Gersh BJ, Gore JM, Levy D, Long JB, O&#x2019;Connor CM, O&#x2019;Gara PT, Ogedegbe G, Oparil S and White WB; American Heart Association, American College of Cardiology, and American Society of Hypertension. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. Circulation 2015; 131: e435-70.","DOI":"10.1161\/CIR.0000000000000207"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0168284.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:29:26Z","timestamp":1779344966000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/11\/ajtr0168284.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/zihr3267","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}